rs148815814

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_015375.3(DSTYK):​c.1775G>A​(p.Arg592Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,614,004 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R592W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

DSTYK
NM_015375.3 missense

Scores

8
6
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 7.91

Publications

4 publications found
Variant links:
Genes affected
DSTYK (HGNC:29043): (dual serine/threonine and tyrosine protein kinase) This gene encodes a dual serine/threonine and tyrosine protein kinase which is expressed in multiple tissues. It is thought to function as a regulator of cell death. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
DSTYK Gene-Disease associations (from GenCC):
  • congenital anomalies of kidney and urinary tract 1
    Inheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 23
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
  • complex hereditary spastic paraplegia
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.032061845).
BP6
Variant 1-205162079-C-T is Benign according to our data. Variant chr1-205162079-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 224356.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00124 (188/152172) while in subpopulation AFR AF = 0.00407 (169/41514). AF 95% confidence interval is 0.00357. There are 1 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSTYKNM_015375.3 linkc.1775G>A p.Arg592Gln missense_variant Exon 6 of 13 ENST00000367162.8 NP_056190.1 Q6XUX3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSTYKENST00000367162.8 linkc.1775G>A p.Arg592Gln missense_variant Exon 6 of 13 1 NM_015375.3 ENSP00000356130.3 Q6XUX3-1
DSTYKENST00000367161.7 linkc.1775G>A p.Arg592Gln missense_variant Exon 6 of 12 1 ENSP00000356129.3 Q6XUX3-2

Frequencies

GnomAD3 genomes
AF:
0.00124
AC:
188
AN:
152054
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00408
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000334
AC:
84
AN:
251238
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00388
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000152
AC:
222
AN:
1461832
Hom.:
0
Cov.:
31
AF XY:
0.000138
AC XY:
100
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.00376
AC:
126
AN:
33480
American (AMR)
AF:
0.000179
AC:
8
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00166
AC:
66
AN:
39698
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1111960
Other (OTH)
AF:
0.000132
AC:
8
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00124
AC:
188
AN:
152172
Hom.:
1
Cov.:
33
AF XY:
0.00124
AC XY:
92
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00407
AC:
169
AN:
41514
American (AMR)
AF:
0.000523
AC:
8
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000486
Hom.:
0
Bravo
AF:
0.00139
ESP6500AA
AF:
0.00454
AC:
20
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000362
AC:
44
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Congenital anomalies of kidney and urinary tract 1 Uncertain:1
-
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DSTYK-related disorder Benign:1
Jul 08, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Benign
-0.041
T
BayesDel_noAF
Pathogenic
0.17
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.090
.;T;.
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.032
T;T;T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Benign
1.7
L;L;.
PhyloP100
7.9
PrimateAI
Pathogenic
0.82
D
PROVEAN
Uncertain
-2.9
D;D;.
REVEL
Uncertain
0.61
Sift
Uncertain
0.0060
D;D;.
Sift4G
Uncertain
0.019
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.75
MVP
0.91
MPC
1.2
ClinPred
0.094
T
GERP RS
5.9
Varity_R
0.38
gMVP
0.63
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148815814; hg19: chr1-205131207; COSMIC: COSV65688494; API